Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (84)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Crofts, F. G.
Right arrow Articles by Strickland, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crofts, F. G.
Right arrow Articles by Strickland, P. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1969-1973, Copyright © 1998 by Oxford University Press

ARTICLES

Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1

FG Crofts, TR Sutter and PT Strickland
Department of Environmental Health Sciences, The Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205, USA.

While the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) by N-hydroxylation has been well documented, the relative roles of the human cytochrome P450 (CYP) enzymes that catalyze this reaction have not been established. Previous studies indicated that the mutagenic activation product, 2-hydroxyamino-PhIP (N2-OH- PhIP), is produced primarily by CYP1A2, and to a lesser extent by CYP1A1. We recently reported that human CYP1B1 also produces N2-OH-PhIP (Carcinogenesis, 18, 1793-1798, 1997). In the present study, we examined PhIP metabolism by microsomes containing recombinant human CYP1A1, 1A2 or 1B1 expressed in Sf9 insect cells and compared the kinetic values for PhIP metabolite formation. PhIP metabolites were analyzed by high pressure liquid chromatography with fluorescence and absorbance detection. Vmax values for N2-OH-PhIP formation were 90, 16 and 0.2 nmol/min/nmol P450, and the apparent Km values were 79, 5.1 and 4.5 microM for human CYP1A2, 1A1 and 1B1, respectively. The non- mutagenic metabolite, 4'-hydroxy-PhIP, was also formed by all three CYP enzymes with Vmax values of 1.5, 7.8 and 0.3 nmol/ min/nmol P450 and apparent Km values of 43, 8.2 and 2.2 microM for human CYP1A2, 1A1 and 1B1, respectively. Although the Vmax for N2-OH-PhIP production was highest for CYP1A2, the catalytic efficiency (Vmax/Km) of CYP1A1 was greater than that of CYP1A2. These results suggest that, for humans, extrahepatic CYP1A1 may be more important than previously thought for the metabolic activation of the dietary carcinogen PhIP.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
L. Vanhaecke, F. Vercruysse, N. Boon, W. Verstraete, I. Cleenwerck, M. De Wachter, P. De Vos, and T. van de Wiele
Isolation and Characterization of Human Intestinal Bacteria Capable of Transforming the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine
Appl. Envir. Microbiol., March 1, 2008; 74(5): 1469 - 1477.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Creton, H. Zhu, and N. J. Gooderham
The Cooked Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Activates the Extracellular Signal Regulated Kinase Mitogen-Activated Protein Kinase Pathway
Cancer Res., December 1, 2007; 67(23): 11455 - 11462.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. N. Lauber and N. J. Gooderham
The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer
Cancer Res., October 1, 2007; 67(19): 9597 - 9602.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Ma, J. R. Idle, M. A. Malfatti, K. W. Krausz, D. W. Nebert, C.-S. Chen, J. S. Felton, D. J. Waxman, and F. J. Gonzalez
Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Carcinogenesis, March 1, 2007; 28(3): 732 - 737.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. Creton, H. Zhu, and N. J. Gooderham
A Mechanistic Basis for the Role of Cycle Arrest in the Genetic Toxicology of the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Toxicol. Sci., April 1, 2005; 84(2): 335 - 343.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
C G Dietrich, A Geier, H E Wasmuth, S Matern, C Gartung, D R de Waart, and R P J O Elferink
Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen
Gut, December 1, 2004; 53(12): 1850 - 1855.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. N. Lauber, S. Ali, and N. J. Gooderham
The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity
Carcinogenesis, December 1, 2004; 25(12): 2509 - 2517.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. G. Walters, P. J. Young, C. Agus, M. G. Knize, A. R. Boobis, N. J. Gooderham, and B. G. Lake
Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans
Carcinogenesis, September 1, 2004; 25(9): 1659 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Zhu, P. Chang, M. L. Bondy, A. A. Sahin, S. E. Singletary, S. Takahashi, T. Shirai, and D. Li
Detection of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]-Pyridine-DNA Adducts in Normal Breast Tissues and Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 830 - 837.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. D. Terry, J. Lagergren, A. Wolk, G. Steineck, and O. Nyren
Dietary Intake of Heterocyclic Amines and Cancers of the Esophagus and Gastric Cardia
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 940 - 944.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Wilkening, F. Stahl, and A. Bader
COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIES
Drug Metab. Dispos., August 1, 2003; 31(8): 1035 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Sachse, G. Smith, M. J.V. Wilkie, J. H. Barrett, R. Waxman, F. Sullivan, D. Forman, D. T. Bishop, and C.R. Wolf
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Carcinogenesis, November 1, 2002; 23(11): 1839 - 1850.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W.G. Stillwell, R. Sinha, and S.R. Tannenbaum
Excretion of the N2-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans
Carcinogenesis, May 1, 2002; 23(5): 831 - 838.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Murata and S. Kawanishi
Oxidation of 5'-site guanine at GG and GGG sequences induced by a metabolite of carcinogenic heterocyclic amine PhIP in the presence of Cu(II) and NADH
Carcinogenesis, May 1, 2002; 23(5): 855 - 860.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Murray, B. G. Lake, S. Gray, A. J. Edwards, C. Springall, E. A. Bowey, G. Williamson, A. R. Boobis, and N. J. Gooderham
Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man
Carcinogenesis, September 1, 2001; 22(9): 1413 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.-F. Yueh, N. Nguyen, M. Famourzadeh, C. P. Strassburg, Y. Oda, F.P. Guengerich, and R. H. Tukey
The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines
Carcinogenesis, June 1, 2001; 22(6): 943 - 950.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. G. Dietrich, D.R. de Waart, R. Ottenhoff, A. H. Bootsma, A. H. van Gennip, and R. P.J.O. Elferink
Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Carcinogenesis, May 1, 2001; 22(5): 805 - 811.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
N. J. Gooderham, S. Murray, A. M. Lynch, M. Yadollahi-Farsani, K. Zhao, A. R. Boobis, and D. S. Davies
Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans
Drug Metab. Dispos., April 1, 2001; 29(4): 529 - 534.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
J.A. Williams
Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression
Carcinogenesis, February 1, 2001; 22(2): 209 - 214.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. C. Deitz, W. Zheng, M. A. Leff, M. Gross, W.-Q. Wen, M. A. Doll, G. H. Xiao, A. R. Folsom, and D. W. Hein
N-Acetyltransferase-2 Genetic Polymorphism, Well-done Meat Intake, and Breast Cancer Risk among Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 905 - 910.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
J.A. Williams, F.L. Martin, G.H. Muir, A. Hewer, P.L. Grover, and D.H. Phillips
Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue
Carcinogenesis, September 1, 2000; 21(9): 1683 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Williams and D. H. Phillips
Mammary Expression of Xenobiotic Metabolizing Enzymes and Their Potential Role in Breast Cancer
Cancer Res., September 1, 2000; 60(17): 4667 - 4677.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M.-S. Chua, E. Kashiyama, T. D. Bradshaw, S. F. Stinson, E. Brantley, E. A. Sausville, and M. F. G. Stevens
Role of CYP1A1 in Modulation of Antitumor Properties of the Novel Agent 2-(4-Amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in Human Breast Cancer Cells
Cancer Res., September 1, 2000; 60(18): 5196 - 5203.
[Abstract] [Full Text]

Home page
 Toxicol SciHome page
K. M. Gressani, S. Leone-Kabler, M. G. O'Sullivan, A. J. Townsend, and M. S. Miller
Prenatal Toxicity and Lack of Carcinogenicity of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) following Transplacental Exposure
Toxicol. Sci., June 1, 2000; 55(2): 407 - 414.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
J.A. Williams, E. M. Stone, B. C. Millar, A. Hewer, and D. H. Phillips
Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
Mutagenesis, March 1, 2000; 15(2): 149 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Shibutani, A. Fernandes, N. Suzuki, L. Zhou, F. Johnson, and A. P. Grollman
Mutagenesis of the N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine DNA Adduct in Mammalian Cells. SEQUENCE CONTEXT EFFECTS
J. Biol. Chem., September 24, 1999; 274(39): 27433 - 27438.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Leff, P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan, and D. W. Hein
Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 182 - 187.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.